There could be a $35 billion market to treat NASH, a ‘silent disease’ millions are living with — and the competition’s starting to heat up
|04/12/2018||Posted by BusinessMediaguide.Com under General World News||
- NASH, short for nonalcoholic steatohepatitis, is a type of liver disease in which liver fat builds up in people.
- It affects an estimated 16 million Americans, but many don’t know it until it leads to more serious problems like liver failure and cirrhosis.
- Work’s being done to pinpoint how to treat the condition — both early and later as the disease progresses — as well as research that’s being used to better understand the genetics and other factors associated with NASH.
Millions of people are living with a disease they’ve likely never heard of.